TY - JOUR
T1 - TransSynW
T2 - A single-cell RNA-sequencing based web application to guide cell conversion experiments
AU - Ribeiro, Mariana Messias
AU - Okawa, Satoshi
AU - del Sol, Antonio
N1 - Funding Information:
Fonds National de la Recherche Luxembourg, Grant/Award Number: C17/BM/11662681 Funding information
Funding Information:
We thank Sybille Barvaux for helping gather evidence for pioneer factors. We thank Ernest Arenas, Igor Cervenka, and other anonymous researchers for giving us valuable feedbacks for developing the web application. M.M.R. is supported by Fonds National de la Recherche Luxembourg (C17/BM/11662681).
Funding Information:
We thank Sybille Barvaux for helping gather evidence for pioneer factors. We thank Ernest Arenas, Igor Cervenka, and other anonymous researchers for giving us valuable feedbacks for developing the web application. M.M.R. is supported by Fonds National de la Recherche Luxembourg (C17/BM/11662681).
Publisher Copyright:
© 2020 The Authors. STEM CELLS TRANSLATIONAL MEDICINE published by Wiley Periodicals LLC on behalf of AlphaMed Press.
PY - 2021/2
Y1 - 2021/2
N2 - Generation of desired cell types by cell conversion remains a challenge. In particular, derivation of novel cell subtypes identified by single-cell technologies will open up new strategies for cell therapies. The recent increase in the generation of single-cell RNA-sequencing (scRNA-seq) data and the concomitant increase in the interest expressed by researchers in generating a wide range of functional cells prompted us to develop a computational tool for tackling this challenge. Here we introduce a web application, TransSynW, which uses scRNA-seq data for predicting cell conversion transcription factors (TFs) for user-specified cell populations. TransSynW prioritizes pioneer factors among predicted conversion TFs to facilitate chromatin opening often required for cell conversion. In addition, it predicts marker genes for assessing the performance of cell conversion experiments. Furthermore, TransSynW does not require users' knowledge of computer programming and computational resources. We applied TransSynW to different levels of cell conversion specificity, which recapitulated known conversion TFs at each level. We foresee that TransSynW will be a valuable tool for guiding experimentalists to design novel protocols for cell conversion in stem cell research and regenerative medicine.
AB - Generation of desired cell types by cell conversion remains a challenge. In particular, derivation of novel cell subtypes identified by single-cell technologies will open up new strategies for cell therapies. The recent increase in the generation of single-cell RNA-sequencing (scRNA-seq) data and the concomitant increase in the interest expressed by researchers in generating a wide range of functional cells prompted us to develop a computational tool for tackling this challenge. Here we introduce a web application, TransSynW, which uses scRNA-seq data for predicting cell conversion transcription factors (TFs) for user-specified cell populations. TransSynW prioritizes pioneer factors among predicted conversion TFs to facilitate chromatin opening often required for cell conversion. In addition, it predicts marker genes for assessing the performance of cell conversion experiments. Furthermore, TransSynW does not require users' knowledge of computer programming and computational resources. We applied TransSynW to different levels of cell conversion specificity, which recapitulated known conversion TFs at each level. We foresee that TransSynW will be a valuable tool for guiding experimentalists to design novel protocols for cell conversion in stem cell research and regenerative medicine.
KW - cellular therapy
KW - clinical translation
KW - differentiation
KW - direct cell conversion
KW - genomics
KW - reprogramming
KW - synergy
KW - transcription factors
UR - http://www.scopus.com/inward/record.url?scp=85092199637&partnerID=8YFLogxK
UR - https://pubmed.ncbi.nlm.nih.gov/33125830
U2 - 10.1002/sctm.20-0227
DO - 10.1002/sctm.20-0227
M3 - Article
C2 - 33125830
AN - SCOPUS:85092199637
SN - 2157-6564
VL - 10
SP - 230
EP - 238
JO - Stem cells translational medicine
JF - Stem cells translational medicine
IS - 2
ER -